Cargando…

The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [(11)C]-raclopride PET study with aripiprazole

Aripiprazole’s effects on cognitive function in patients with schizophrenia are unclear because of the difficulty in disentangling specific effects on cognitive function from secondary effects due to the improvement in other schizophrenic symptoms. One approach to address this is to use an intermedi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Sangho, Kim, Seoyoung, Seo, Seongho, Lee, Jae Sung, Howes, Oliver D., Kim, Euitae, Kwon, Jun Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913226/ https://www.ncbi.nlm.nih.gov/pubmed/29686254 http://dx.doi.org/10.1038/s41398-018-0134-6

Ejemplares similares

Relationship between subjective well-being and aripiprazole: an [(11)C]raclopride PET study
por: Kim, Seoyoung, et al.
Publicado: (2022)

S145. ANTIPSYCHOTIC DISCONTINUATION IN FIRST EPISODE PSYCHOSIS: [18F]DOPA AND [11C]RACLOPRIDE PET STUDY
por: Kim, Euitae
Publicado: (2018)

T137. THE RELATIONSHIP BETWEEN CORTICOSTRIATAL CONNECTIVITY AND STRIATAL DOPAMINE FUNCTION IN SCHIZOPHRENIA: AN 18F-DOPA PET AND DIFFUSION TENSOR IMAGING STUDY
por: Shin, Sangho, et al.
Publicado: (2020)

The Relationship Between Frontostriatal Connectivity and Striatal Dopamine Function in Schizophrenia: An (18)F-DOPA PET and Diffusion Tensor Imaging Study in Treatment Responsive and Resistant Patients
por: Shin, Sangho, et al.
Publicado: (2022)

S156. FRONTO-STRIATAL FUNCTIONAL CONNECTIVITY AND STRIATAL DOPAMINE CAPACITY IN TREATMENT-RESPONSIVE AND REFRACTORY SCHIZOPHRENIA
por: Kim, Seoyoung, et al.
Publicado: (2018)

Mapping the landscape of human dopamine D2/3 receptors with [(11)C]raclopride
por: Papenberg, Goran, et al.
Publicado: (2019)

Raclopride-Molecularly Imprinted Polymers: A Promising Technology for Selective [(11)C]Raclopride Purification
por: Del Sole, Roberta, et al.
Publicado: (2023)

PM438. Functional connectivity and striatal dopamine synthesis in schizophrenia treated with antipsychotic drugs: multimodal imaging study using [18F]DOPA PET and resting MRI
por: Kim, Euitae, et al.
Publicado: (2016)

Investigating expectation and reward in human opioid addiction with [(11)C]raclopride PET
por: Watson, Ben J, et al.
Publicado: (2014)

Comparison of PET template-based and MRI-based image processing in the quantitative analysis of C(11)-raclopride PET
por: Kuhn, Felix P, et al.
Publicado: (2014)

The relationship between grey matter volume and striatal dopamine function in psychosis: a multi-modal (18)F-DOPA PET and voxel-based morphometry study
por: D’Ambrosio, Enrico, et al.
Publicado: (2021)

Measurement of Striatal Dopamine Release Induced by Neuropsychological Stimulation in Positron Emission Tomography With Dual Injections of [(11)C]Raclopride
por: Ikoma, Yoko, et al.
Publicado: (2022)

Levodopa effects on [ (11)C]raclopride binding in the resting human brain
por: Black, Kevin J., et al.
Publicado: (2015)

Harmonization of [(11)C]raclopride brain PET images from the HR+ and HRRT: method development and validation in human subjects
por: Hoye, Jocelyn, et al.
Publicado: (2022)

Relationship of Change in Plasma Clozapine/N-desmethylclozapine Ratio with Cognitive Performance in Patients with Schizophrenia
por: Park, Royun, et al.
Publicado: (2020)

A simultaneous [(11)C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism
por: Zürcher, Nicole R., et al.
Publicado: (2021)

Dopamine D2/3-receptor availability and its association with autonomous motivation to exercise in older adults: An exploratory [(11)C]-raclopride study
por: Simonsson, Emma, et al.
Publicado: (2022)

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
por: Takase, Masayuki, et al.
Publicado: (2015)

Review of depot aripiprazole for schizophrenia
por: Motiwala, Farha Bilal, et al.
Publicado: (2013)

Impact of an Adenosine A(2A) Receptor Agonist and Antagonist on Binding of the Dopamine D(2) Receptor Ligand [(11)C]raclopride in the Rodent Striatum
por: Prasad, Kavya, et al.
Publicado: (2022)

Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect
por: Wiker, Charlotte, et al.
Publicado: (2005)

Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and, in parallel, its antipsychotic-like effect
por: Wiker, Charlotte, et al.
Publicado: (2005)

Potential Effect of Prolonged Sevoflurane Anesthesia on the Kinetics of [(11)C]Raclopride in Non-human Primates
por: Arakawa, Ryosuke, et al.
Publicado: (2017)

Associations of Clozapine Use With Psychosocial Functioning and Quality of Life in Patients With Schizophrenia: A Community-Based Cross-Sectional Study
por: Kim, Sujin, et al.
Publicado: (2021)

Effects of Dopamine D(2) Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[β-(11)C]DOPA
por: Ito, Hiroshi, et al.
Publicado: (2012)

Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms
por: McCutcheon, Robert A., et al.
Publicado: (2019)

Aripiprazole for late-life schizophrenia
por: Rado, Jeffrey, et al.
Publicado: (2010)

Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study
por: Llorca, Pierre-Michel, et al.
Publicado: (2022)

Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent (11)C-raclopride positron emission tomography and functional magnetic resonance imaging investigation
por: Hamilton, J. Paul, et al.
Publicado: (2018)

S203. EFFECT OF LONG-ACTING INJECTIONS OF PALIPERIDONE PALMITATE ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH SCHIZOPHRENIA BASED ON ILLNESS DURATION
por: Kim, Seoyoung, et al.
Publicado: (2020)

Role of aripiprazole in treatment-resistant schizophrenia
por: Mossaheb, Nilufar, et al.
Publicado: (2012)

Molecular imaging as a guide for the treatment of central nervous system disorders
por: Kim, Euitae, et al.
Publicado: (2013)

Enhanced Dopamine in Prodromal Schizophrenia (EDiPS): a new animal model of relevance to schizophrenia
por: Petty, Alice, et al.
Publicado: (2019)

The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [(11)C] Raclopride Binding in Tau Mouse Models of Alzheimer’s Disease
por: Jimenez, Heidy, et al.
Publicado: (2023)

Binding kinetics of cariprazine and aripiprazole at the dopamine D(3) receptor
por: Frank, Annika, et al.
Publicado: (2018)

Aripiprazole: the evidence of its therapeutic impact in schizophrenia
por: Winlow, William, et al.
Publicado: (2006)

Effect of Aripiprazole on Mismatch Negativity (MMN) in Schizophrenia
por: Zhou, Zhenhe, et al.
Publicado: (2013)

Aripiprazole-associated tic in a schizophrenia patient
por: Guo, Xieli, et al.
Publicado: (2015)

Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone
por: Lee, Bong Ju, et al.
Publicado: (2013)

Effectiveness of Switching to Long-acting Injectable Aripiprazole in Patients with Recent-onset and Chronic Schizophrenia
por: Kim, Sung-Wan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b34sapq0o5ffl1r5rgekk2kqem